Live Breaking News & Updates on Channel Bioscience

Stay updated with breaking news from Channel bioscience. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Biohaven Acquires Kv7 Ion Channel Platform for the Treatment of Epilepsy and Other Neurologic Disorders From Channel Biosciences, a Subsidiary of Knopp Biosciences

/PRNewswire/ Biohaven Pharmaceutical Holding Company Ltd. (NYSE: BHVN; the "Company" or "Biohaven") announced today that it has entered into a definitive. ....

United States , Michael Bozik , Irfan Qureshi , Jen Porcelli , Steven Dworetzky , Knopp Biosciences , Mike Beyer , Biohaven Neuroinnovation , Biohaven Pharmaceuticals , Exchange Commission On , Company Or Biohaven , World Health Organization , Sam Brown Inc , Exchange Commission , Company Annual Report On Form , Biohaven Pharmaceutical Holding Company Ltd , Bristol Myers Squibb , Channel Biosciences , Biohaven Pharmaceutical Holding Company , Chief Executive Officer , World Health , Vice President , Channel Bioscience , Biohaven Labs , New Drug Approval , Chief Scientific Officer ,

Biohaven pays $100M for epilepsy drug prospect; strikes deal for BMS muscle med

Neuroscience drug developer Biohaven Pharmaceuticals is expanding its pipeline to include epilepsy and spinal muscular atrophy. The drug developer is acquiring Channel Bioscience and licensing global rights to a Phase 3-ready drug from Bristol Myers Squibb. ....

Michael Bozik , Knopp Biosciences , Xenon Pharmaceuticals , Bausch Health Companies , Bristol Myers Squibb , Valeant Pharmaceuticals , Biohaven Pharmaceutical , Channel Bio , Connecticut Based Biohaven , Pittsburgh Based Knopp , Scholar Rock , Weight Loss , Medical Devices , Healthcare Innovation , Medcity News , Medcity News , San Francisco , Life Sciences , Rock Health , Startup Advice , Startup Funding , Patient Monitoring System , Otion Sensors , Healthcare It , Foodborne Pathogens , Iagnostics Company ,